首页> 外文期刊>ACS medicinal chemistry letters >Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase
【24h】

Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase

机译:HIV逆转录酶嵌合抑制剂的设计,合成和抗病毒评价

获取原文
获取原文并翻译 | 示例
           

摘要

In a continuing study of potent bifunctional anti- HIV agents, we rationally designed a novel chimeric inhibitor utilizing thymidine (THY) and a TMC derivative (a diarylpyrimidine NNRTI) linked via a polymethylene linker (ALK). The nucleoside, 5′-hydrogen-phosphonate (H-phosphonate), and 5′-triphosphate forms of this chimeric inhibitor (THY-ALKTMC) were synthesized and the antiviral activity profiles were evaluated at the enzyme and cellular level. The nucleoside triphosphate (11) and the H-phosphonate (10) derivatives inhibited RT polymerization with an IC_(50) value of 6.0 and 4.3 nM, respectively. Additionally, chimeric nucleoside (9) and Hphosphonate (10) derivatives reduced HIV replication in a cellbased assay with low nanomolar antiviral potencies.
机译:在对有效的双功能抗HIV药物的持续研究中,我们合理设计了利用胸苷(THY)和通过聚亚甲基接头(ALK)连接的TMC衍生物(二芳基嘧啶NNRTI)的新型嵌合抑制剂。合成了该嵌合抑制剂(THY-ALKTMC)的核苷,5'-磷酸氢盐(H-膦酸酯)和5'-三磷酸形式,并在酶和细胞水平评估了抗病毒活性。三磷酸核苷(11)和H-膦酸酯(10)衍生物抑制RT聚合,IC_(50)值分别为6.0和4.3 nM。此外,嵌合核苷(9)和氢膦酸盐(10)衍生物在基于细胞的测定中具有较低的纳摩尔抗病毒效力,从而减少了HIV复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号